Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

Lancet
V PérezF Artigas

Abstract

Major depression affects more than 5% of the population and is a serious health and economic problem. Antidepressants have a slow onset of action and are effective in less than two-thirds of patients. The biochemical effects of selective serotonin reuptake inhibitors may be limited by the negative feedback from serotonin autoreceptors. Pindolol is an antagonist of both serotonin autoreceptors and beta-adrenoceptors. We studied the effect of the addition of pindolol to fluoxetine antidepressant treatment. Of 132 eligible patients with major depression, 111 were randomly assigned to treatment with fluoxetine (20 mg daily) and either placebo or pindolol (7.5 mg daily). Patients were assessed twice a week for the first 3 weeks of active treatment and then once a week until the end of the study (42 days). Hamilton and Montgomery-Asberg depression-rating scales were used to assess depression severity. The proportion of patients who responded to treatment with fluoxetine and pindolol was greater than that with fluoxetine and placebo (41/55 [75%] vs 33/56 [59%], [90% CI 1.1-30.1], p = 0.04). The proportion of patients who achieved a sustained response was also greater in the fluoxetine and pindolol group than in the fluoxetine and plac...Continue Reading

References

Jan 1, 1992·Psychotherapy and Psychosomatics·R Rothschild, F M Quitkin
Jan 1, 1991·Journal of Biopharmaceutical Statistics·G G Koch
Jan 1, 1989·Journal of Clinical Epidemiology·K E Peace
Jan 17, 1986·JAMA : the Journal of the American Medical Association·J AvornS Weiss
Jun 1, 1995·Journal of Clinical Psychopharmacology·P Blier, R Bergeron
Jan 1, 1994·International Clinical Psychopharmacology·G D Tollefson, S L Holman
Mar 1, 1994·International Clinical Psychopharmacology·J Hyttel
Jul 1, 1993·Trends in Pharmacological Sciences·F Artigas
Jun 1, 1993·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H H StassenJ Angst
Oct 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·L RomeroP Blier

❮ Previous
Next ❯

Citations

Sep 17, 2008·Psychopharmacology·E Estrada-CamarenaA Fernández-Guasti
Mar 23, 2004·European Journal of Pharmacology·Ewa TatarczyńskaEwa Chojnacka-Wójcik
May 17, 2005·Neuroscience and Biobehavioral Reviews·James M O'DonnellLewis S Seiden
Apr 20, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Abdalla Salem Elhwuegi
Jun 9, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Alessandro SerrettiEnrico Smeraldi
Apr 23, 2003·Biological Psychiatry·Lori L AltshulerMichael J Gitlin
Feb 1, 2002·European Journal of Pharmacology·Maxime RicherPierre Blier
May 22, 2002·European Journal of Pharmacology·Rosa M TorderaBerta Lasheras
Nov 11, 1998·European Journal of Pharmacology·I Hervás, F Artigas
Sep 30, 1999·Life Sciences·D K Raap, L D Van de Kar
Jul 27, 1999·Pharmacology, Biochemistry, and Behavior·J C WinterR A Rabin
Jul 26, 2003·Journal of Affective Disorders·Per Plenge, Erling T Mellerup
May 8, 2001·Trends in Pharmacological Sciences·F ArtigasA Adell
Nov 8, 2001·Trends in Pharmacological Sciences·F Chaouloff
Aug 16, 2000·Journal of Clinical Epidemiology·T J KaptchukW B Stason
May 1, 1998·European Psychiatry : the Journal of the Association of European Psychiatrists·D Hackett
May 1, 1998·European Psychiatry : the Journal of the Association of European Psychiatrists·N LaugeP Bech
May 4, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·P N DannonJ Zohar
Dec 15, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H J KochD Hannak
Mar 26, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Pierre Blier
Oct 16, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M Isaac
Jan 26, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H Yan, T Lewander
Nov 27, 1999·Bioorganic & Medicinal Chemistry Letters·M B van NielA M MacLeod
Aug 30, 2000·Nuclear Medicine and Biology·P J Cowen
Aug 30, 2000·Nuclear Medicine and Biology·B AndréeL Farde

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.